Table 1 Patients characteristics
Patient age | Gender | ATL subtype | Response at day 30 | Best response | Initial viral load (copy/μl) | Viral load at day 30 (copy/μl) |
|---|---|---|---|---|---|---|
58 | F | Acute | PR | PR | 105483 | 219 |
56 | M | Acute | PR | PR | NA | NA |
60 | M | Chronic | PR | CR | NA | NA |
47 | F | Chronic | VGPR | CR | 1990 | 336 |
53 | M | Chronic | PR | CR | 84 | 33 |
72 | M | Chronic | VGPR | CR | 548 | 0 |
36 | M | Chronic | VGPR | VGPR | 999 | 838 |
46 | F | Chronic | VGPR | CR | NA | NA |
63 | F | Chronic | PR | CR | 1081 | 63 |
51 | F | Chronic | PR | CR | 196 | 64 |
68 | F | Chronic | VGPR | VGPR | 1805 | 65 |
60 | M | Chronic | PR | CR | 47 | 7 |
53 | M | Chronic | PR | PR | 49724 | 18898 |
77 | M | Chronic | VGPR | CR | 3747 | 182 |
54 | M | Lymphoma | NR | NR | NA | NA |
48 | M | Lymphoma | PR | CR | NA | NA |